Zomedica Corp. Depreciation & Amortization 2011-2026 | ZOM

Annual Depreciation & Amortization Zomedica Corp.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.06 M	1.54 M	830 K	426 K	265 K	306 K	277 K	204 K	89.6 K	43.1 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.06 M	43.1 K	604 K

Quarterly Depreciation & Amortization Zomedica Corp.

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
506 K	509 K	521 K	-	417 K	351 K	334 K	-	198 K	176 K	164 K	-	109 K	161 K	82 K	-	60 K	55 K	59 K	-	78.2 K	77.9 K	76.4 K	-	277 K	277 K	277 K	-	204 K	204 K	204 K	-	89.6 K	89.6 K	89.6 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
521 K	55 K	209 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Canopy Growth Corporation CGC	21.5 M	$ 1.07	4.9 %	$ 115 M	Canada
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
Assertio Holdings ASRT	30 M	$ 12.5	6.2 %	$ 80 M	USA
DURECT Corporation DRRX	31 K	-	-	$ 50.1 M	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	-	-	$ 2.06 B	France
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Evolus EOLS	7.51 M	$ 4.91	-2.58 %	$ 317 M	USA
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
Cumberland Pharmaceuticals CPIX	4.9 M	$ 3.01	-1.63 %	$ 42.3 M	USA
Jupiter Wellness JUPW	429 K	-	-	$ 33.6 M	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
Organogenesis Holdings ORGO	13.6 M	$ 2.53	-1.94 %	$ 333 M	USA
Harrow Health HROW	1.32 M	$ 35.23	0.92 %	$ 1.3 B	USA
Pacira BioSciences PCRX	78.8 M	$ 21.94	-3.31 %	$ 1.01 B	USA
Emergent BioSolutions EBS	125 M	$ 8.08	-3.0 %	$ 414 M	USA
China Pharma Holdings CPHI	2.62 M	$ 0.61	-1.52 %	$ 10.7 M	China
Veru VERU	268 K	$ 2.41	1.69 %	$ 325 M	USA
ProPhase Labs PRPH	4.72 M	-	-	$ 5.07 M	USA
TherapeuticsMD TXMD	922 K	$ 2.23	2.76 %	$ 23.3 M	USA
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
Viatris VTRS	2.74 B	$ 13.8	2.15 %	$ 16.6 B	USA
Perrigo Company plc PRGO	338 M	$ 10.3	5.86 %	$ 1.43 B	USA
Neoleukin Therapeutics NLTX	3.26 M	-	-	$ 193 M	Canada
Sonoma Pharmaceuticals SNOA	138 K	$ 2.4	-0.41 %	$ 2.98 M	USA
Relmada Therapeutics RLMD	1.26 K	$ 6.45	4.37 %	$ 194 M	USA
Rockwell Medical RMTI	1.44 M	$ 1.06	10.96 %	$ 24.7 M	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
SCYNEXIS SCYX	580 K	$ 0.92	2.39 %	$ 45.9 M	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
Solid Biosciences SLDB	2.46 M	$ 7.76	3.74 %	$ 317 M	USA
Tilray TLRY	35.7 M	$ 6.95	0.72 %	$ 4.29 B	Canada
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
cbdMD YCBD	452 K	$ 0.75	4.53 %	$ 3.23 M	USA
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA